Omni Health, Inc.

OMHE

US68216X1046

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:38:45 2024-04-15 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-80.00%		-.--%	-.--%

2017	Omni Health Seeks Acquisitions	CI
2017	Omni Health, Inc. Announces Executive Changes	CI

Omni Health Announces Opening of Biotech Research Lab in Miami, Florida

May 04, 2017 at 06:00 am EDT

Omni Health, Inc. announced the opening of its biotech R&D and manufacturing laboratory facility in Miami, Florida.

Latest news about Omni Health, Inc.

Omni Health Seeks Acquisitions	17-12-12	CI
Omni Health, Inc. Announces Executive Changes	17-07-21	CI
Omni Health, Inc. Appoints Dr. Lawrence E. Samuels to Its Scientific Advisory Board	17-06-01	CI
Omni Health Announces Opening of Biotech Research Lab in Miami, Florida	17-05-04	CI
Omni Health Seeks Acquisitions	17-05-03	CI
Omni Health, Inc. announced that it has received $1 million in funding	17-05-02	CI
Omni Health, Inc. Reports Financial Results for the Third Quarter and Year to Date Ended January 31, 2017	17-03-09	CI
Omni Health Mulls Acquisitions	17-02-09	CI
Omni Health, Inc. Announces Earnings Result for the Second Quarter Ended October 31, 2016	17-02-01	CI
Omni Health Inc. Announces Earnings Results for the First Quarter Ended July 31, 2016	17-01-23	CI
Omni Health, Inc. Announces Executive Changes	17-01-18	CI
VitaCig, Inc. will Change its Name to Omni Health Inc	16-11-21	CI
VitaCig, Inc. will Change its Ticker to OMHE from VTCQ	16-11-21	CI
VitaCig, Inc. Announces Board Changes	16-10-06	CI
VitaCig, Inc. Receives $100,000 Purchase Order	16-09-19	CI
Malecon Pharmacy, Inc. acquired VitaCig, Inc. in a reverse merger transaction.	16-06-26	CI
MCig, Inc.(OTCPK: MCIG) acquired assets and operations from VitaCig, Inc. for $0.98 million.	16-06-26	CI

Omni Health, Inc. is an integrated healthcare company. The Company is focused on the development of pharmaceuticals, anti-aging products, and biotech engineering. The Companyâs subsidiary is Malecon Pharmacy, Inc., which is engaged in healthcare services and operates in the lucrative pharmaceutical, medical and wellness industries.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
OMNI HEALTH, INC.	-.--%	1.48K
ELI LILLY AND COMPANY	+29.68%	699B
NOVO NORDISK A/S	+25.07%	571B
JOHNSON & JOHNSON	-4.35%	364B
MERCK & CO., INC.	+17.65%	326B
ABBVIE INC.	+3.77%	286B
ASTRAZENECA PLC	+14.68%	236B
NOVARTIS AG	+4.71%	198B
ROCHE HOLDING AG	-12.43%	194B
PFIZER, INC.	-3.79%	154B

Other Pharmaceuticals

Omni Health, Inc.

Equities

OMHE

US68216X1046

Pharmaceuticals

Omni Health Announces Opening of Biotech Research Lab in Miami, Florida

Latest news about Omni Health, Inc.

Chart Omni Health, Inc.

Company Profile

Sector Other Pharmaceuticals